Cargando…

Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States

BACKGROUND: Atrial fibrillation (AF) prevalence estimates vary and have been based on cohorts with clinically established or diagnosed disease. Undiagnosed AF prevalence estimates are less certain as they are based on nongeneralizable convenience samples. HYPOTHESIS: Because AF is often asymptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turakhia, Mintu P., Guo, Jennifer D., Keshishian, Allison, Delinger, Rachel, Sun, Xiaoxi, Ferri, Mauricio, Russ, Cristina, Cato, Matthew, Yuce, Huseyin, Hlavacek, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189075/ https://www.ncbi.nlm.nih.gov/pubmed/36855960 http://dx.doi.org/10.1002/clc.23983

Ejemplares similares

Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database
por: Munir, Muhammad Bilal, et al.
Publicado: (2022)

Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants
por: Lip, Gregory Y. H., et al.
Publicado: (2022)

Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database
por: Munir, Muhammad Bilal, et al.
Publicado: (2022)

Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
por: Atwater, Brett D., et al.
Publicado: (2023)

Estimated prevalence of undiagnosed atrial fibrillation in the United States
por: Turakhia, Mintu P., et al.
Publicado: (2018)

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
por: Lip, Gregory Y. H., et al.
Publicado: (2021)

Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High‐risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation (STUDY‐AF)
por: Turakhia, Mintu P., et al.
Publicado: (2015)

Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
por: Dhamane, Amol D., et al.
Publicado: (2022)

Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
por: Dhamane, Amol D, et al.
Publicado: (2021)

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients
por: Deitelzweig, Steven, et al.
Publicado: (2019)

Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes
por: Heo, Nam Ju, et al.
Publicado: (2020)

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer
por: Deitelzweig, Steven, et al.
Publicado: (2021)

Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients
por: Perino, Alexander C., et al.
Publicado: (2022)

Accuracy of Smartphone Camera Applications for Detecting Atrial Fibrillation: A Systematic Review and Meta-analysis
por: O’Sullivan, Jack W., et al.
Publicado: (2020)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
por: Yong, Celina M., et al.
Publicado: (2020)

Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population
por: Amin, Alpesh, et al.
Publicado: (2019)

Cost-Effectiveness of Cardiac Radiosurgery for Atrial Fibrillation: Implications for Reducing Health Care Morbidity, Utilization, and Costs
por: Bhatt, Nikhilesh, et al.
Publicado: (2016)

Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database
por: Guo, Jennifer D., et al.
Publicado: (2020)

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients
por: Deitelzweig, Steven, et al.
Publicado: (2021)

Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
por: Deitelzweig, Steven, et al.
Publicado: (2021)

Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical Trial
por: Ha, Andrew C. T., et al.
Publicado: (2021)

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
por: Cohen, Alexander, et al.
Publicado: (2021)

Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases
por: Lip, Gregory Y. H., et al.
Publicado: (2022)

Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure
por: Amin, Alpesh, et al.
Publicado: (2019)

Risk of Dementia After Smoking Cessation in Patients With Newly Diagnosed Atrial Fibrillation
por: Lee, Hui-Jin, et al.
Publicado: (2022)

Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease
por: Cohen, Alexander T., et al.
Publicado: (2021)

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
por: Fox, Keith A. A., et al.
Publicado: (2020)

Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status
por: Cohen, Alexander T., et al.
Publicado: (2021)

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
por: Cohen, Alexander T., et al.
Publicado: (2022)

Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020
por: Ko, Darae, et al.
Publicado: (2022)

Individual and Combined Risk Factors for Incident Atrial Fibrillation and Incident Stroke: An Analysis of 3 Million At-Risk US Patients
por: Chyou, Janice Y, et al.
Publicado: (2015)

The Left Atrial Appendage and Atrial Fibrillation—A Contemporary Review
por: Sulague, Ralf Martz, et al.
Publicado: (2023)

2135 Impact of primary care physician gatekeeping on medication prescriptions for atrial fibrillation
por: Chang, Andrew Y., et al.
Publicado: (2018)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
por: Pundi, Krishna N., et al.
Publicado: (2021)

Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation
por: Menekşe Gerede, Demet, et al.
Publicado: (2016)

ACC/AHA Hypertension Guidelines and CHA(2)DS(2)-VASc Up-Scoring in Patients With Atrial Fibrillation
por: Pundi, Krishna, et al.
Publicado: (2023)

Estimating the Population Prevalence of Diagnosed and Undiagnosed Diabetes
por: Leong, Aaron, et al.
Publicado: (2013)

Hybrid Ablation of Atrial Fibrillation: A Contemporary Overview
por: Marini, Massimiliano, et al.
Publicado: (2022)

A Discussion of the Contemporary Prediction Models for Atrial Fibrillation
por: Rosenberg, Michael A., et al.
Publicado: (2023)

Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study
por: Grundvold, Irene, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_35mvnqmuvbifb6hrsaq259ptfj